Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

Completed

Conditions studied: Fatigue, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children

In brief

RATIONALE: Gathering information about metabolic syndrome from young patients with acute lymphoblastic leukemia may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients with acute lymphoblastic leukemia in remission.

Key facts

Study ID

NCT00801346

Run by

Vanderbilt University Medical Center

People needed

224

Starts

2008-11-01

Expected to finish

2016-04-01

Last updated by the study team

2017-04-21

Who can join

Age: 1 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Vanderbilt-Ingram Cancer Center - Cool Springs — Nashville, Tennessee, United States
• Vanderbilt-Ingram Cancer Center at Franklin — Nashville, Tennessee, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.